The CDC recommends all adults be screened for hepatitis B (HBV), hepatitis C (HCV), and HIV at least once.1-3 These infections often progress silently, and patients with conditions like diabetes face even greater risks.4,5 Universal screening helps uncover infections earlier, prevent transmission, and support better outcomes. We offer CDC-aligned panels to make screening easier for you and your patients. Learn more. http://spr.ly/60477sY6R ¹ CDC: http://spr.ly/60497sY6T ² CDC: http://spr.ly/60417sY6V ³ CDC:http://spr.ly/60427sY6n ⁴ CDC: http://spr.ly/60447sY6k ⁵ DOR: http://spr.ly/60457sY6Z
Quest Diagnostics
Medical and Diagnostic Laboratories
Secaucus, NJ 348,813 followers
Working together to create a healthier world, one life at a time.
About us
Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s. The company reported 2020 revenues of $9.44 billion. Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories. Patients may have specimens collected in any of the company’s approximately 2,250 patient service centers. On a typical workday, testing is performed for about 550,000 patients. Quest Diagnostics empowers healthcare organizations & clinicians with state-of-the-art connectivity solutions. The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals. More information is available at www.questdiagnostics.com. Language Assistance / Non-Discrimination Notice Asistencia de Idiomas / Aviso de no Discriminación 語言協助 / 不歧視通知 www.QuestDiagnostics.com/home/nondiscrimination
- Website
-
http://www.questdiagnostics.com
External link for Quest Diagnostics
- Industry
- Medical and Diagnostic Laboratories
- Company size
- 10,001+ employees
- Headquarters
- Secaucus, NJ
- Type
- Public Company
- Founded
- 1967
- Specialties
- Diagnostic testing information and services, Clinical testing, cancer diagnostics and anatomic pathology services, Gene-based and other esoteric testing, and Healthcare information technology solutions
Products
Quanum Practice Management
Medical Practice Management Software
Increase the efficiency of your practice with Quanum™ Practice Management. Manage patient appointments, billing & more. Get info today!
Locations
-
Primary
Get directions
500 Plaza Drive
Secaucus, NJ 07094, US
Employees at Quest Diagnostics
Updates
-
Early diagnosis of type 1 diabetes (T1D) is crucial to limiting complications and improving outcomes. Early signs can be absent or ambigiuous, and lack of risk awareness can delay differential diagnosis. Our new article details how comprehensive autoantibody screening for T1D can enable earlier identification, even before symptoms develop. Read more: http://spr.ly/60487opt2 #AmericanDiabetesMonth #DiabetesAwareness
-
As the prevalence of type 2 diabetes (T2DM) continues to rise, insulin resistance and poor glycemic control in turn drive comorbid cardiometabolic disease. T2DM and other related cardiometabolic conditions share risk factors, but often go undiagnosed in early stages when intervention can be most effective. Our new article details a streamlined option to identify and monitor the intersection of cardiometabolic disease presence and downstream effects across organ systems. Read more: http://spr.ly/60447opYa #AmericanDiabetesMonth #DiabetesAwareness
-
The Hologic® Genius™ Digital Diagnostics System is the first and only FDA-cleared groundbreaking digital cytology platform to screen for cervical cancer by using an artificial intelligence algorithm and high-definition monitor to help identify precancerous and cancer cells, unlocking new levels of efficiency for the cytotechnologist and/or pathologist and can provide more sensitive disease detection than manual and image-guided review. According to Anthony R. Henderson, Quest’s National Laboratory Operations Director for Cytology, “This integration marks a big step forward in how we approach diagnostic accuracy and efficiency in cervical cancer screening.”
-
-
Quest Diagnostics reposted this
I’ve said a lot recently about the power of lab testing in driving a shift toward wellness in healthcare, and this week brought one of those moments when you get to see your mission come to life real-time. I was honored to spend time with our great partners at Function Health and join Jonathan Swerdlin onstage at the Function Function to talk about our collective vision for care that starts with health, not sickness. Jonathan, his co-founders Mark Hyman, MD and Pranitha Patil, and the full Function team, are onto something special and truly transformative – empowering people to understand what’s going on in their own body and illuminating paths to better, more preventive-led care. Together, we’re working to give you insights at your fingertips to own your health because we all want to live longer – and have quality, not just quantity, in our years. That’s Function’s core goal, and ours too. In Quest Diagnostics' purpose, "working together to create a healthier world, one life at a time," that word together is critical — we know we can't do it alone, and we are proud to work with innovative partners like Function Health to bring our collective vision to life.
-
-
When metabolic dysfunction or insulin resistance are identified early, intervention can prevent progression to type 2 diabetes. Traditional A1c and glucose testing don’t always tell the full story. Our new article details tools that can improve assessment of glycemic control and identify metabolic risk sooner. Read more: http://spr.ly/60497cN11 #AmericanDiabetesMonth #DiabetesAwareness
-
On behalf of our genetic services team, thank you for connecting with us at this year's National Society of Genetic Counselors (NSGC) 44th Annual Conference in Seattle, WA. You care deeply and so do we. Let’s continue connecting! #NSGC25 #GeneChat
-
At Quest, we invest in a work environment where employees want to grow, thrive, and stay. Proud to appear on TIME's 2026 list of Best Companies for Future Leaders. #TheQuestWay #FutureLeaders #BestCompanies #HealthcareLeadership